Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Help viewing PDFs:

Media Centre

Welcome to the Media Centre

This section provides details of new items added to the site as well as a full archive of our press releases and statements. 

The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.

The Press Office
5th Floor
151 Buckingham Palace Road
Victoria
LONDON
SW1W 9SZ

Main telephone: 020 3080 7651
Out of hours: 07770 446 189
press.office@mhra.gsi.gov.uk

For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.

We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time. 

Press enquiries should be made through the Press Office.


Latest news and press releases

30 Jul 2014 | Commission on Human Medicines recruiting for Commissioners

The Commission on Human Medicines (CHM) is currently recruiting for Commissioners with expertise in medical statistics/biostatistics, epidemiology – with an interest in clinical trials, clinical virology, and a lay representative.

25 Jul 2014 | Advertisement for MHRA chairman published in the Sunday Times

An advertisement for the post of MHRA chairman appeared in the Sunday Times on 20 July 2014.

24 Jul 2014 | Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight

The EMA have concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether the effectiveness of Levonelle (containing levonorgestrel) and ellaOne (containing ulipristal acetate) was reduced with increased body weight.

24 Jul 2014 | Press release: European review concludes positive benefit risk of emergency contraceptives

Emergency contraceptives continue to be suitable for all women who need them, regardless of the woman’s weight said the Medicines and Healthcare products Regulatory Agency (MHRA) today. These medicines may continue to be used to prevent unintended pregnancies and should be taken as soon as possible after unprotected intercourse or contraceptive failure. This follows a European review that concluded that the benefits of emergency contraceptives continue to outweigh the risks in all women.

21 Jul 2014 | MHRA opioids learning module updated

We have updated our popular learning module on opioids. The changes cover recent concerns about transdermal patches.  We have also revised one or two of the self-assessment questions.

The unwanted display of the text is removed here...dont delete this

Photo and image library

This section provides downloadable MHRA-related images suitable for print output, including images of our Executive Board.
The unwanted display of the text is removed here...dont delete this

What's new

Man on computer
This section lists details of new information added to the MHRA website.

Press releases

Man reading a newspaper

This section of the site includes press releases and statements issued by the MHRA.

Press Office contacts

Woman with telephone headset
This section gives phone numbers and email addresses for all the MHRA press contacts.
Page last modified: 14 July 2014